Upstream Bio Stock Analysis

Upstream Stock Analysis Notes

About 15.0% of the company outstanding shares are owned by insiders. The book value of Upstream Bio was at this time reported as 7.01. The company recorded a loss per share of 6.4. Upstream Bio had not issued any dividends in recent years. For more information please call MD MPH at 781 208 2466 or visit https://upstreambio.com.

Upstream Bio Investment Alerts

Upstream Largest EPS Surprises

View All Earnings Estimates

Upstream Bio Environmental, Social, and Governance (ESG) Scores

Upstream Market Capitalization

The company currently falls under 'Mid-Cap' category with a total capitalization of 1.26 B.

Upstream Profitablity

Management Efficiency

Upstream Bio has Return on Asset of (0.2815) % which means that on every $100 spent on assets, it lost $0.2815. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.408) %, meaning that it generated no profit with money invested by stockholders. Upstream Bio's management efficiency ratios could be used to measure how well Upstream Bio manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.12. In addition to that, Return On Capital Employed is expected to decline to -0.16. At present, Upstream Bio's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 3.1 M, whereas Other Current Assets are forecasted to decline to about 5.6 M.

Technical Drivers

As of the 2nd of January, Upstream Bio has the Risk Adjusted Performance of 0.1353, coefficient of variation of 555.51, and Semi Deviation of 3.27. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Upstream Bio, as well as the relationship between them.

Upstream Bio Price Movement Analysis

Upstream Bio Insider Trading Activities

Upstream Bio Outstanding Bonds

Upstream Bio Predictive Daily Indicators

Upstream Bio Corporate Filings

Upstream Bio Forecast Models

Upstream Bio's time-series forecasting models are one of many Upstream Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Upstream Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Upstream Bio Bond Ratings

Upstream Bio financial ratings play a critical role in determining how much Upstream Bio have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Upstream Bio's borrowing costs.

Upstream Bio Total Assets Over Time

Upstream Bio Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Upstream Bio uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Upstream Bio Debt Ratio

0.34

It appears most of the Upstream Bio's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Upstream Bio's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Upstream Bio, which in turn will lower the firm's financial flexibility.

Upstream Bio Corporate Bonds Issued

Upstream Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Upstream Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Upstream shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Upstream Bio. By using and applying Upstream Stock analysis, traders can create a robust methodology for identifying Upstream entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Upstream analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Upstream analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Upstream Bio stock analysis indicators help investors evaluate how Upstream Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Upstream Bio shares will generate the highest return on investment. By understating and applying Upstream Bio stock analysis, traders can identify Upstream Bio position entry and exit signals to maximize returns.

When running Upstream Bio's price analysis, check to measure Upstream Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Upstream Bio is operating at the current time. Most of Upstream Bio's value examination focuses on studying past and present price action to predict the probability of Upstream Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Upstream Bio's price. Additionally, you may evaluate how the addition of Upstream Bio to your portfolios can decrease your overall portfolio volatility.